Completed or ongoing FDA Clinical Trial Studies for TG4010 & TG4040
Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer Condition: Carcinoma, Non-Small-Cell Lung Intervention: Biological: MVA-MUC1-IL2
Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients Condition: Chronic Hepatitis C Infection Interventions: Drug: pegylated interferon and ribavirin; Biological: TG4040 + SOC
Immunotherapy With TG4040 in Treatment-na?ve Patients Chronically Infected With Hepatitis C Virus Condition: Hepatitis C, Chronic Intervention: Biological: MVA-HCV (Immunotherapy)